KLOW 80mg is a four-compound research blend that combines GHK-Cu, BPC-157, TB-500, and KPV in a single lyophilized vial. It is studied as a KLOW 80mg peptide blend for multi-pathway research — bringing tissue-repair, angiogenic, and anti-inflammatory peptides together at fixed ratios so a research model can be exposed to all four compounds at once, without reconstituting four separate vials. This guide covers exactly what is in KLOW, how each compound is studied, how the blend is reconstituted, expected vial longevity, and the quality standards that matter. KLOW is supplied strictly for laboratory research use.
What Is KLOW 80mg?
KLOW 80mg is a pre-formulated peptide blend containing 80mg of total net peptide content across four compounds. The “80” in the name refers to the combined milligram weight of all four peptides in the vial. KLOW is one of two flagship CoreVionRX research blends — the four-compound KLOW and the three-compound GLOW. Where a single peptide targets one pathway, the KLOW blend is built for researchers studying overlapping repair and inflammatory pathways at the same time. If you have searched “what is KLOW 80” or “klow 80mg what is it,” the short answer is: a fixed-ratio four-peptide research blend totaling 80mg.
KLOW 80mg Composition and Ingredients
The KLOW peptide blend composition is built around a high-mass copper peptide base with three supporting compounds. The full KLOW peptide blend ingredients are:
| Compound | Amount | Primary Research Role |
|---|---|---|
| GHK-Cu | 50mg | Copper-binding tripeptide — collagen synthesis, gene-expression regulation |
| BPC-157 | 10mg | Body Protection Compound — angiogenesis, wound-healing models |
| TB-500 | 10mg | Thymosin Beta-4 fragment — cell migration, actin regulation |
| KPV | 10mg | Alpha-MSH fragment — anti-inflammatory (NF-κB pathway) |
| Total net peptide | 80mg | |
Each of the four components carries a lot-specific Certificate of Analysis confirming identity and purity, not just total mass.
The Four Compounds and Their Research Mechanisms
GHK-Cu (50mg) — The Foundation of the Blend
GHK-Cu (Glycyl-L-Histidyl-L-Lysine Copper) is the largest component by mass and the backbone of KLOW. It is a naturally occurring copper-binding tripeptide found in human plasma, and research has examined its role in collagen synthesis, fibroblast activity, and the regulation of matrix metalloproteinases. Notably, gene-expression studies have associated GHK-Cu with the modulation of thousands of genes tied to tissue remodeling and the inflammatory response, which is why it is studied as a foundational “signal” peptide in repair models.
BPC-157 (10mg)
BPC-157 is a 15-amino-acid partial sequence derived from a protein found in gastric juice. It is one of the most extensively studied compounds in angiogenesis and wound-healing research, with models focusing on tendon-to-bone healing, new blood-vessel formation, and gastrointestinal tissue repair. Its stability and consistent angiogenic signal make it a common pairing with TB-500.
TB-500 (10mg)
TB-500 is the biologically active fragment of thymosin beta-4 (amino acids 17–23). Research focuses on its role in actin regulation, cell migration, and the promotion of new blood-vessel formation. It is frequently studied alongside BPC-157 because the two act through complementary tissue-repair pathways rather than the same one.
KPV (10mg)
KPV (Lys-Pro-Val) is a tripeptide fragment from the C-terminal region of alpha-MSH (alpha-melanocyte-stimulating hormone). It is studied for anti-inflammatory activity, particularly through modulation of the NF-κB signaling pathway. KPV is the component that distinguishes KLOW from the three-compound GLOW blend, adding an explicit anti-inflammatory dimension to the formula.
Why KLOW Is Studied as a Multi-Pathway Blend
The logic behind KLOW is overlap. GHK-Cu drives remodeling and gene-expression signaling; the BPC-157 and TB-500 pairing covers angiogenesis and cell migration; KPV adds anti-inflammatory modulation. Studying these as a fixed-ratio blend lets a research model engage tissue-repair and inflammatory pathways simultaneously, while controlling for relative dosing across the four peptides. It also removes a major source of variability — reconstituting, measuring, and administering four separate compounds — which is why the KLOW 80mg peptide blend for multi-pathway research has become a standard tool in comparative repair studies.
KLOW vs GLOW: What Is the Difference?
GLOW is a 70mg three-component blend (GHK-Cu + BPC-157 + TB-500). KLOW is the 80mg four-component blend that adds KPV. In practice: GLOW is the tissue-repair and angiogenesis blend; KLOW is GLOW plus a dedicated anti-inflammatory peptide. Researchers comparing single-pathway versus multi-pathway approaches frequently run both side by side.
How to Reconstitute KLOW 80mg
KLOW reconstitution follows the same principles as any lyophilized peptide: bacteriostatic water is added slowly down the side of the vial, never injected directly onto the powder, and the vial is swirled rather than shaken until fully dissolved. Because KLOW contains four peptides at 80mg total, the reconstitution volume you choose determines the concentration of every component proportionally. A common approach is to reconstitute with a volume that produces convenient working concentrations for the research model. For full step-by-step technique, see our complete reconstitution guide, and use the preparation calculator to convert any reconstitution volume into exact per-unit concentrations.
KLOW Research Protocols and Working Concentrations
Because KLOW is a fixed-ratio blend, research protocols are typically expressed as a total blend amount per administration in the model, which then breaks down proportionally across the four compounds (GHK-Cu making up roughly 62.5% of any given amount, with BPC-157, TB-500, and KPV each contributing 12.5%). When designing a KLOW 80mg protocol, researchers calculate the working concentration from their chosen reconstitution volume and then determine per-use volumes from there. The preparation calculator handles this conversion so the four-peptide ratio stays consistent across the study.
How Long Does an 80mg KLOW Vial Last?
Vial longevity is simple arithmetic: total milligrams divided by the per-use amount used in the research model equals the number of uses. An 80mg vial used at, for example, 2mg of total blend per administration would yield roughly 40 uses; at 4mg per administration, roughly 20. The exact figure depends entirely on the protocol design. Once reconstituted, the blend should be refrigerated and used within the stability window appropriate for the compounds; lyophilized (unreconstituted) KLOW stored frozen has a substantially longer shelf life.
Quality Standards: COA and Purity
A four-peptide blend raises the bar for verification. The Certificate of Analysis should confirm the identity and purity of each individual component — not simply the combined mass. CoreVionRX supplies KLOW with a lot-specific COA including HPLC purity (≥99%) and mass-spectrometry identity confirmation for each of the four peptides. For researchers, this is the difference between knowing you have 80mg of “something” and knowing you have a verified 50/10/10/10 split of the correct compounds.
Where to Buy KLOW 80mg
KLOW 80mg is available directly from CoreVionRX with third-party testing and a lot-specific COA included. For current KLOW peptide price and availability, visit the KLOW product page. Researchers comparing blends may also want to review the tissue repair peptides category and the three-compound GLOW blend.
Frequently Asked Questions
What is KLOW 80mg?
KLOW 80mg is a four-compound research blend containing GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) — 80mg of total net peptide in one lyophilized vial, studied for multi-pathway tissue-repair and anti-inflammatory research.
What is in the KLOW peptide blend?
The KLOW blend composition is GHK-Cu 50mg, BPC-157 10mg, TB-500 10mg, and KPV 10mg. GHK-Cu makes up the majority of the mass, with the three supporting peptides each at 10mg.
How do you reconstitute KLOW 80mg?
Add bacteriostatic water slowly down the side of the vial and swirl gently until dissolved. The reconstitution volume sets the concentration of all four peptides proportionally. A preparation calculator converts your chosen volume into exact per-unit concentrations.
How long does an 80mg KLOW vial last?
Divide 80mg by the per-use amount in your research model. At 2mg per use, an 80mg vial yields about 40 uses; at 4mg per use, about 20. The exact number depends on protocol design.
What is the difference between KLOW and GLOW?
GLOW is a 70mg three-peptide blend (GHK-Cu + BPC-157 + TB-500). KLOW is an 80mg four-peptide blend that adds KPV, a tripeptide studied for anti-inflammatory activity. KLOW is the more comprehensive multi-pathway blend.
Is KLOW for human use?
No. KLOW and all CoreVionRX peptides are supplied strictly for laboratory research use. They are not approved for human or veterinary use and must not be administered to humans or animals.
View KLOW 80mg product details and pricing →
Research availability: KLOW 80mg peptide blend is available from CoreVionRX with ≥99% HPLC purity and a lot-specific Certificate of Analysis. For laboratory research use only.
